[1]
Tonne, P., Do, D., Hasan, N., Gundapaneni, S., Reddy, A., Sridharan, S. and Richardson, S. 2021. The Role of the Gut Microbiome in Neuromodulation Therapies as a Potential Treatment Adjunct for Multiple Sclerosis. Berkeley Pharma Tech Journal of Medicine. 1, 1 (Dec. 2021), 64–94. DOI:https://doi.org/10.52243/bptjm.v1i1.15.